Key result
Chymase inhibition with NK3201 significantly reduced left ventricular end-diastolic pressure and cardiac fibrosis compared to vehicle in rats after myocardial infarction.
Why the study?
Does chymase inhibition with NK3201 prevent cardiac fibrosis and dysfunction after myocardial infarction in rats?
Does chymase inhibition with NK3201 prevent cardiac fibrosis and dysfunction after myocardial infarction in rats?
Absolute Event Rate: 6% vs 10%
p-value: p=<0.01
In a rat model of myocardial infarction, chymase inhibition with NK3201 prevented cardiac fibrosis and preserved diastolic function, suggesting a potential therapeutic target for post-MI remodeling.
No takes yet. Share an insight, caveat, or question.
Chymase inhibition may attenuate post-MI remodeling in rats; hypothesis-generating and requires human trials before any clinical consideration.
Kanemitsu et al. (2006) studied Myocardial infarction (n=18). NK3201 vs. Vehicle was evaluated on Left ventricular end-diastolic pressure (LVEDP) at 4 weeks (p=<0.01). Chymase inhibition with NK3201 significantly reduced left ventricular end-diastolic pressure and cardiac fibrosis compared to vehicle in rats after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: